SLACK Inc., the publisher of HemOnc Today, has announced the launch of a new subspecialty publication, Cell Therapy Next. The publication will debut at the American Society of Hematology Annual Meeting & Exposition on December 1-4, 2018 in San Diego. The publication is set to print six times a year.
Cell Therapy Next will lay the groundwork in explaining how cellular therapy has developed and why many believe this could be a paradigm shift in the treatment of a range of cancers. As the publication continues, it will track the state of the science, providing updates on the clinical development of new agents and the results of clinical trials. The publication will also provide updates on late preclinical research and the results of efforts to bring this treatment strategy to solid tumors.
Cell Therapy Next will serve as a practical guide for the clinician, with articles and information on selecting the ideal patient, educating patients on the complex treatment process, managing side effects and the risk profile of these new agents.
Cell Therapy Next is set to launch at the American Society for Hematology annual meeting December 1-4 in San Diego.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
